Indianapolis, IN, United States of America

Michael S Vannieuwenhze

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael S Vannieuwenhze. Retrieved from https://idiyas.com/inventor/michael-s-vannieuwenhze

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael S. Vannieuwenhze: Innovator in Anti-Viral Compounds

Introduction

Michael S. Vannieuwenhze is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-viral compounds. His work has the potential to impact public health positively.

Latest Patents

Michael holds a patent for anti-viral compounds, showcasing his innovative approach to combating viral infections. This patent reflects his commitment to advancing medical science and improving treatment options.

Career Highlights

Michael is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly allows him to work on cutting-edge research and development projects that aim to address critical health challenges.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues, including Kurt D. Schladetzky and Wayne A. Spitzer. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Michael S. Vannieuwenhze is a dedicated inventor whose work in anti-viral compounds exemplifies the spirit of innovation in the pharmaceutical industry. His contributions are vital in the ongoing fight against viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…